Effects of Psychotropic Medications on Pancreatic Function: A Review

References

• Dostert P, Benedetti MS. Biochemical mechanisms of the hep- atotoxicity of psychotropic drugs [In French with an English abstract]. Encephale 1984;10:199–209.
   Google Scholar
• Thomson NM. Drugs and the kidney in the elderly. Med J Aust 1995;162:543–7.
   Google Scholar
• Balon R, Berchou R. Hematologic side effects of the psy- chotropic drugs. Psychosomatics 1986;27:119–20, 125–7.
   Google Scholar
• Wilmink T, Frick TW. Drug-induced pancreatitis. Drug Safety 1996;14:406–23.
   PubMed Web of Science ®Google Scholar
• Runzi M, Layer P. Drug-associated pancreatitis: facts and fic- tion. Pancreas 1996;13:100–9.
   PubMed Web of Science ®Google Scholar
• Karch FE, Lasagna L. Adverse drug reactions: a critical re- view. JAMA 1975;234:1236–41.
   PubMed Web of Science ®Google Scholar
• Asconape JJ, Penry JK, Dreifuss FE, Riela A, Mirza W. Valproate-associated pancreatitis. Epilepsia 1993;34:177–83.
   PubMed Web of Science ®Google Scholar
• Rosenberg HK, Ortega W. Hemorrhagic pancreatitis in a young child following valproic acid therapy. Clin Pediatr 1987; 26:98–101.
   PubMed Web of Science ®Google Scholar
• Binek J, Hany A, Heer M. Valproic-acid-induced pancreatitis: case report and review of the literature. J Clin Gastroenterol 1991;13:690–3.
   Google Scholar
• Isom JB. On the toxicity of valproic acid. Am J Dis Child 1984; 138:901–3.
   Google Scholar
• Walker RM, Smith GS, Barsoum NJ, Macallum GE. Preclini- cal toxicology of the anticonvulsant calcium valproate. Toxicol- ogy 1990;63:137–55.
   PubMed Web of Science ®Google Scholar
• Pippenger CE, Meng X, Van Lente F, Rothner AD. Valproate therapy depresses free radical scavenging enzyme activity: a probable mechanism for induction of acute pancreatitis or hepatotoxicity [Abstract]. Neurology 1989;39(suppl 1):214.
   Google Scholar
• Sanfey H, Bulkley GB, Cameron JL. The role of oxygen- derived free radicals in the pathogenesis of acute pancreatitis. Ann Surg 1984;200:405–13.
   PubMed Web of Science ®Google Scholar
• Martin A. Acute pancreatitis associated with clozapine use [Letter]. Am J Psychiatry 1992;149:714.
   PubMed Web of Science ®Google Scholar
• Frankenburg FR, Kando J. Eosinophilia, clozapine, and pan- creatitis [Letter]. Lancet 1992;340:251.
   PubMed Web of Science ®Google Scholar
• Jubert P. Clozapine-related pancreatitis [Letter]. Ann Intern Med 1994;121:722–3.
   PubMed Web of Science ®Google Scholar
• Fullerton F, McPhillips M, Edelman K, Riccio M. Acute pan- creatitis in association with clozapine. New Trends Exp Clin Psychiatry 1994;10:149–51.
   Google Scholar
• Chengappa KNR, Pelucio M, Baker RW, Cole D. Recurrent pancreatitis on clozapine re-challenge. J Psychopharmacol 1995;9:381–2.
   Google Scholar
• Cerulli TR. Clozapine-associated pancreatitis. Harvard Rev Psychiatry 1999;7:61–3.
   Google Scholar
• Ghaeli P, Dufresne RL. Serum triglyceride levels in patients treated with clozapine. Am J Health Syst Pharm 1996;53:2079–81.
   PubMed Web of Science ®Google Scholar
• Tsao CY, Wright FS. Acute chemical pancreatitis associated with carbamazepine intoxication. Epilepsia 1993;34:174–6.
   PubMed Web of Science ®Google Scholar
• Roberge RJ, Martin TG, Hodgman M, Benitez JG. Acute chemical pancreatitis associated with a tricyclic antidepres- sant (clomipramine) overdose. J Toxicol Clin Toxicol 1994;32:425–9.
   PubMed Web of Science ®Google Scholar
• Stecyk O, Loludice TA, Demeter S, Jacobs J. Multiple organ failure resulting from intravenous abuse of methylphenidate hydrochloride. Ann Emerg Med 1985;14:597–9.
   PubMed Web of Science ®Google Scholar
• Bourry J, Sainty JM, Roux JJ, Ressiot G. Pancre´atites aigue¨s au cours d’intoxications au me´probamate: roˆle e´ventuel de la the´rapeutique par amines pressives. Nouv Presse Med 1976; 5:1918.
   Google Scholar
• El-Dakhakhny M, Abdel el-Latif HA, Ammon HPT. Different effects of the antidepressant drugs imipramine, maprotiline and bupropion on insulin secretion from mouse pancreatic is- lets. Arzneimittelforschung 1996;46:667–9.
   Google Scholar
• Paykel ES, Mueller PS, De la Vergne PM. Amitriptyline, weight gain and carbohydrate craving: a side effect. Br J Psy- chiatry 1973;123:501–7.
   Google Scholar
• Nakra BR, Rutland P, Verma S, Gaind R. Amitriptyline and weight gain: a biochemical and endocrinological study. Curr Med Res Opin 1977;4:602–6.
   PubMed Web of Science ®Google Scholar
• Van Praag HM, Leijnse B. The influence of some antidepres- sant drugs of the hydrazine type on the glucose metabolism in depressed patients. Clin Chim Acta 1963;8:466–75.
   PubMed Web of Science ®Google Scholar
• Adnitt PI. Hypoglycemic action of monoamineoxidase inhibi- tors (MAOI’s). Diabetes 1968;17:628–33.
   Google Scholar
• Cooper AJ, Ashcroft G. Potentiation of insulin hypoglycaemia by MAOI antidepressant drugs. Lancet 1966;1:407–9.
   Google Scholar
• Bressler R, Vargas-Cordon M, Lebovitz HE. Tranylcypromine: a potent insulin secretagogue and hypoglycemic agent. Diabe- tes 1968;17:617–24.
   Google Scholar
• Bresler R, Johnson D. New pharmacological approaches to therapy of NIDDM. Diabetes Care 1992;15:792–805.
   Google Scholar
• Rowland MJ, Bransome ED Jr, Hendry LB. Hypoglycemia caused by selegiline, an antiparkinsonian drug: can such side effects be predicted? J Clin Pharmacol 1994;34:80–5.
   Google Scholar
• Potter van Loon BJ, Radder JK, Fro¨lich M, Krans HM, Zwin- derman AH, Meinders AE. Fluoxetine increases insulin action in obese nondiabetic and in obese non-insulin-dependent dia- betic individuals. Int J Obes Relat Metab Disord 1992;16:79–85.
   Google Scholar
• Maheux P, Ducros F, Bourque J, Garon J, Chiasson JL. Fluox- etine improves insulin sensitivity in obese patients with non- insulin-dependent diabetes mellitus independently of weight loss. Int J Obes Relat Metab Disord 1997;21:97–102.
   PubMed Web of Science ®Google Scholar
• Wilson GA, Furman BL. Effects of inhibitors of 5-hydroxy- tryptamine uptake on plasma glucose and their interaction with 5-hydroxytryptophan in producing hypoglycaemia in mice. Eur J Pharmacol 1982;78:263–70.
   PubMed Web of Science ®Google Scholar
• Goodnick PJ, Henry JH, Buki VM. Treatment of depression in patients with diabetes mellitus. J Clin Psychiatry 1995;56:128–36.
   PubMed Web of Science ®Google Scholar
• Russell JD, Johnson GFS. Affective disorders, diabetes melli- tus and lithium. Aust NZ J Psychiatry 1981;15:349–53.
   Web of Science ®Google Scholar
• Kondziela JR, Kaufmann MW, Klein MJ. Diabetic ketoacidosis associated with lithium: case report. J Clin Psychiatry 1985; 46:492–3.
   Google Scholar
• Caviezel F, Cattaneo AG, Cetta G, Pozza G. Influence of short- term lithium carbonate administration on stimulated insulin secretion in normal man. Int J Clin Pharmacol Ther Toxicol 1987;25:188–93.
   Google Scholar
• Lahtela JT. Effect of long-term anticonvulsant therapy on glu- cose metabolism in humans. Epilepsia 1986;27:711–6.
   Google Scholar
• Isoja¨ rvi JIT, Laatikainen TJ, Knip M, Pakarinen AJ, Juntunen KT, Myllyla¨ VV. Obesity and endocrine disorders in women taking valproate for epilepsy. Ann Neurol 1996;39:579–84.
   Google Scholar
• Isoja¨ rvi JIT, Ra¨ ttya¨ J, Myllyla¨ VV, Knip M, Koivunen R, Pakarinen AJ, et al. Valproate, lamotrigine, and insulin- mediated risks in women with epilepsy. Ann Neurol 1998;43:446–51.
   Google Scholar
• Porte D Jr. Beta adrenergic stimulation of insulin release in man. Diabetes 1967;16:150–5.
   Google Scholar
• Quicken KE Jr, Feldman JM, Lebovitz HE. Inhibition of insu- lin secretion by serotonin and dopamine: species variation. Endocrinology 1971;89:1295–302.
   Google Scholar
• Neck FS, Foldenauer A, Zeller G, Wolf CF, Pfeiffer EF. Com- parative effects of dopamine and dobutamine on glucoreg- ulation in a rat model. Can J Physiol Pharmacol 1991;69:1178–83.
   Google Scholar
• Valenzuela JE, Defilippi C, Diaz G, Navia E, Merino Y. Effect of dopamine on human gastric and pancreatic secretion. Gas- troenterology 1979;76:323–6.
   PubMed Web of Science ®Google Scholar
• Leblanc H, Lachelin GC, Abu-Fadil S, Yen SS. The effect of dopamine infusion on insulin and glucagon secretion in man. J Clin Endocrinol Metab 1977;44:196–8.
   PubMed Web of Science ®Google Scholar
• Hiles BW. Hyperglycemia and glycosuria following chlorprom- azine therapy [Letter]. JAMA 1956;162:1651.
   Web of Science ®Google Scholar
• Arneson GA. Phenothiazine derivatives and glucose metabo- lism. J Neuropsychiatry 1964;5:181–5.
   PubMedGoogle Scholar
• Thonnard-Neumann E. Phenothiazines and diabetes in hospi- talized women. Am J Psychiatry 1968;124:978–82.
   PubMed Web of Science ®Google Scholar
• Ammon HP, Orci L, Steinke J. Effect of chlorpromazine (CPZ) on insulin release in vivo and in vitro in the rat. J Pharmacol Exp Ther 1973;187:423–9.
   Google Scholar
• Federspil G, Casara D, Stauffacher W. Chlorpromazine in the treatment of endogenous organic hyperinsulinism. Diabeto- logia 1974;10:189–91.
   Google Scholar
• Scandellari C, Zaccaria M, Sicolo N, Casara D, Erle G, Feders- pil G. Medical treatment of endogenous organic hyperinsulin- ism. Horm Metab Res Suppl 1976;6:46–54.
   Google Scholar
• Erle G, Basso M, Federspil G, Sicolo N, Scandellari C. Effect of chlorpromazine on blood glucose and plasma insulin in man. Eur J Clin Pharmacol 1977;11:15–18.
   PubMedGoogle Scholar
• Brambilla F, Guerrini A, Guastalla A, Rovere C, Riggi F. Neu- roendocrine effects of haloperidol therapy in chronic schizo- phrenia. Psychopharmacologia 1975;44:17–22.
   Google Scholar
• Hermansen K. Haloperidol, a dopaminergic antagonist: soma- tostatin-like inhibition of glucagon and insulin release from the isolated, perfused canine pancreas. Diabetologia 1978;15:343–7.
   Google Scholar
• Samols E, Stagner JI. Reinterpretation of the effect of haloper- idol and ethanol on insulin secretion. Diabetologia 1980;19:81–3.
   Google Scholar
• Iijima F, Iwatsuki K, Chiba S. Effects of dopamine on exocrine secretion and cyclic nucleotide concentration in the dog pan- creas. Eur J Pharmacol 1983;92:191–7.
   Google Scholar
• Furuta Y, Hashimoto K, Iwatsuki K, Takeuchi O. Effects of enzyme inhibitors of catecholamine metabolism and of halo- peridol on the pancreatic secretion induced by L-DOPA and by dopamine in dogs. Br J Pharmacol 1973;47:77–84.
   Google Scholar
• Pazo JH, Vaccaro MI, Tumilasci OR, Murer GM, Calvo EL. Changes in pancreatic exocrine secretion after repeated halo- peridol administration. J Auton Nerv Syst 1989;28:189–92.
   Google Scholar
• Ha¨ gg S, Joelsson L, Mjo¨rndal T, Spigset O, Oja G, Dahlqvist R. Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications. J Clin Psychiatry 1998;59:294–9.
   Google Scholar
• Rutishauser M. Beeinflussung des Kohlenhydrat-Stoffwech- sels des Rattenhirns durch Psychopharmaka mit sedativer Wirkung. Arch Exp Pathol 1963;245:396–413.
   Google Scholar
• Steinbach LH, Randall LO, Gustofson SR. 1,5-Benzo- diazepines. In: Gordon M (ed). Psychopharmacological agents. New York: Academic, 1964:198–200.
   Google Scholar
• Zumoff B, Hellman L. Aggravation of diabetic hyperglycemia by chlordiazepoxide. JAMA 1977;237:1960–1.
   Google Scholar
• Desborough JP, Hall GM, Hart GR, Burrin JM. Midazolam modifies pancreatic and anterior pituitary hormone secretion during upper abdominal surgery. Br J Anaesth 1991;67:390–6.
   Google Scholar
• Odes HS, Bank S, Barbezat GO, Novis BH, Outim L. The ef- fect of diazepam on human pancreatic secretion. S Afr Med J 1976;50:1141–3.
   Google Scholar
• Saunders JHB, Masoero G, Wormsley KG. Effect of diazepam and hyoscine butylbromide on response to secretin and chole- cystokinin-pancreozymin in man. Gut 1976;17:351–3.
   PubMed Web of Science ®Google Scholar
• Fleischer K. Drugs and exocrine pancreatic function in man. Acta Hepatogastroenterol 1978;25:162–5.
   Google Scholar
• Soman M, Swenson C. A possible case of carbamazepine- induced pancreatitis. Drug Int Clin Pharm 1985;19:925–7.
   Google Scholar
• Keane FBV, Fennell JS, Tomkin GH. Acute pancreatitis, acute gastric dilation and duodenal ileus following refeeding in an- orexia nervosa. Ir J Med Sci 1978;147:191–2.
   PubMed Web of Science ®Google Scholar
• Amery A, Vandenbroucke J, Desbuquoit JL, De Groote J. Pan- creatitis during clonidine treatment. Tijdschr Gastroenterol 1973;16:179–85.
   Google Scholar
• Rominger JM, Gutierrez JG, Curtis D, Chey WY. Methyldopa- induced pancreatitis. Am J Dig Dis 1978;23:756–8.
   PubMedGoogle Scholar
• Warren SE, Mitas JA II, Swerdlin AHR. Pancreatitis due to methyldopa: case report. Mil Med 1980;145:399–400.
   Google Scholar
• Van der Heide H, Ten Haaft MA, Stricker BHC. Pancreatitis caused by methyldopa. BMJ 1981;282:1930–1.
   Google Scholar
• Berent I, Carabeth J, Cordero MM, Cordero R, Sugerman B, Robinson D. Pancreatitis associated with risperidone treat- ment [Letter]. Am J Psychiatry 1997;154:130–1.
   Google Scholar